Medtronic board of directors Helping us fulfill our Mission with passion and integrity Meet our members Patients and Caregivers Overview Conditions Treatments & Therapies Electromagnetic Compatibility Guide for Cardiac Devices Order Diabetes Supplies Healthcare Professionals Overview Therapies & ...
View bio EVP, Global Operations & Supply Chain View bio Brett Wall EVP & President, Neuroscience Portfolio View bio Matt Walter Chief Human Resources Officer View bio Ken Washington SVP & Chief Technology and Innovation Officer View bio Medtronic board of directors ...
Medtronic named one of the top 300 most sustainable companies in the U.S. 50/50 Women on Boards –“3+” company on the Gender Diversity Directory™ Medtronic recognized for having three or more women on our board of directors and as a leading company that values the business imperative ...
“We are delighted to have Kevin Lofton join our Board of Directors,” said Geoff Martha, Medtronic chief executive officer. “Kevin’s deep expertise in leading healthcare systems that serve a broad base of communities across the country will bring new perspectives and insight. His diverse ...
Neil Fraser of Medtronic Canada Appointed as Chair of the MEDEC Board of DirectorsAbout MEDEC
Board of Directors Geoffrey Straub Martha Chairman & Chief Executive Officer Lidia L. Fonseca Independent Director Craig Arnold Lead Independent Director Kevin E. Lofton Independent Director Scott C. Donnelly Independent Director Randall J. Hogan III Independent Director Elizabeth G. Nabel Indep...
Board of Directors Geoffrey Straub Martha Chairman & Chief Executive Officer Gregory P. Lewis Independent Director Craig Arnold Lead Independent Director Scott C. Donnelly Independent Director Randall J. Hogan III Independent Director Elizabeth G. Nabel Independent Director Kendall J. Powell Ind...
This would represent FY25 diluted non-GAAP EPS growth in the range of 4 to 6%. Dividend IncreaseThe company today announced that effective May 22, 2024, the Medtronic board of directors approved an increase in Medtronic’s cash dividend for the first quarter ...
The cash-and-stock transaction, which was unanimously approved by the board of directors of both companies, is valued at $93.22 per Covidien share, based on Medtronic’s closing stock price on June 13, 2014, of $60.70 per share. Medtronic Inc.,a Fortune 500 firm founded in 1949, is the...
Tengion taps Medtronic CSO Kuntz for board Tengion Inc. (NSDQ:TNGN) announced that it has appointed Richard Kuntz, M.D., M.Sc., senior vice president and chief scientific, clinical and regulatory officer of Medtronic Inc. (NYSE:MDT), to its board of ...